XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Sep. 30, 2019
Current Assets:    
Cash and cash equivalents $ 36,386 $ 30,361
Available-for-sale securities 24,178 24,931
Accounts receivable, net of allowance for doubtful accounts of $133 and $200 as of June 30, 2020 and September 30, 2019, respectively 8,657 8,993
Contract assets — royalties and license fees 4,248 8,210
Inventories, net 5,872 4,501
Income tax receivable 4,867 558
Prepaids and other 3,594 3,866
Total Current Assets 87,802 81,420
Property and equipment, net 28,939 29,748
Deferred income taxes 5,585 6,176
Intangible assets, net 12,585 14,226
Goodwill 26,563 26,171
Other assets 5,024 2,124
Total Assets 166,498 159,865
Current Liabilities:    
Accounts payable 1,375 2,085
Accrued liabilities:    
Compensation 4,320 4,581
Accrued other 4,703 4,790
Deferred revenue 5,229 5,553
Contingent consideration   3,200
Total Current Liabilities 15,627 20,209
Deferred revenue, less current portion 12,423 11,628
Other long-term liabilities 7,865 5,512
Total Liabilities 35,915 37,349
Commitments and Contingencies (Note 16)
Stockholders’ Equity:    
Series A Preferred stock — $.05 par value, 450,000 shares authorized; no shares issued and outstanding
Common stock — $.05 par value, 45,000,000 shares authorized; 13,645,174 and 13,504,102 shares issued and outstanding as of June 30, 2020 and September 30, 2019, respectively 682 675
Additional paid-in capital 13,658 10,740
Accumulated other comprehensive income 1,469 396
Retained earnings 114,774 110,705
Total Stockholders’ Equity 130,583 122,516
Total Liabilities and Stockholders’ Equity $ 166,498 $ 159,865